Recently, another novel dual-targeting 68Ga-NODAGA-LacN-E[c(RGDfK)]2Glycopeptide has also been developed for PET imaging of cancer patients, which can diagnose integrin αvβ3 and galectin-3 expression in tumor and tumor endothelial cells [104]. Here, LGALS3 is linked to neoplasm.